. .
Bruker Daltonics
Bruker

Time-course Reproducibility of Clinical Samples using Retentate Chromatography MALDI-TOF Mass Spectrometry

Type: Application

Poster

Expression Proteomics

Number: Technology

ASMS 2010

MALDI-TOF

Year Products

2010

  Author
 

Sabine Jourdain(1), Amanda Bulman(2), Waltraud Passlack(3), Sonja Hartwig(3), Akos Czibere(4), Stefan Lehr(3), Fiona Plows(2) and Enrique Dalmasso(2); 1Bio-Rad Laboratories, Division Bio-Recherche, Marnes la Coquette, France; 2Bio-Rad Laboratories, Inc., Hercules, CA, USA; 3Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Dusseldorf, Germany; 4Harvard Stem Cell Institute, Boston, MA, USA

  Reference
 

ASMS 2010

 

Abstract

 

IntroductionSuccess for biomarker discovery projects in clinical proteomics relies primarily on analytical and long-term reproducibility. Sample collection, sample preparation and performance of analytical instruments can all contribute to output signal variability. In order to ensure that discovered differences of expression are physiological and not introduced by experimental variability, any biomarker discovery study should include a means to monitor reproducibility. 

 

Related Products

 

ASMS 2010

 

Download

 

Register with us
In order to get access to all our multimedia specials, additional content and to subscribe to our informative Daltonics E-Dispatch newsletter, please register to our website.